Cargando…
Intermittent parathyroid hormone enhances the healing of medication-related osteonecrosis of the jaw lesions in rice rats
Medication-related osteonecrosis of the jaw (MRONJ) is a potentially severe adverse event in patients treated with antiresorptives. Management of MRONJ is challenging, and no non-antibiotic, established medical treatment exists. Intermittent parathyroid hormone (iPTH) has been used off-label to trea...
Autores principales: | Castillo, E. J., Jiron, J. M., Croft, C. S., Freehill, D. G., Castillo, C. M., Kura, J., Yarrow, J. F., Bhattacharyya, I., Kimmel, D. B., Aguirre, J. Ignacio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10315582/ https://www.ncbi.nlm.nih.gov/pubmed/37404809 http://dx.doi.org/10.3389/fmed.2023.1179350 |
Ejemplares similares
-
Zoledronate treatment duration is linked to bisphosphonate‐related osteonecrosis of the jaw prevalence in rice rats with generalized periodontitis
por: Messer, Jonathan G., et al.
Publicado: (2019) -
Zoledronic acid increases the prevalence of medication-related osteonecrosis of the jaw in a dose dependent manner in rice rats (Oryzomys palustris) with localized periodontitis
por: Messer, J.G., et al.
Publicado: (2017) -
Bisphosphonates, vitamin D, parathyroid hormone, and osteonecrosis
of the jaw. Could there be a missing link?
por: Leizaola-Cardesa, Ignacio-Osoitz, et al.
Publicado: (2016) -
Osteonecrosis of the Jaw
por: Lončar Brzak, Božana, et al.
Publicado: (2023) -
Denosumab and osteonecrosis of the jaw
por: Bower, Robert
Publicado: (2019)